Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114718113 | 11471811 | 3 | F | 2012 | 20160720 | 20150908 | 20160803 | EXP | US-BAYER-2015-410273 | BAYER | 45.00 | YR | A | F | Y | 99.77000 | KG | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114718113 | 11471811 | 1 | PS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 500 MG, UNK | 19537 | 500 | MG | TABLET | ||||||||
| 114718113 | 11471811 | 2 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 500 MG, UNK | 19537 | 500 | MG | TABLET | ||||||||
| 114718113 | 11471811 | 3 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 500 MG, UNK | 19537 | 500 | MG | TABLET | ||||||||
| 114718113 | 11471811 | 4 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 250 MG, UNK | 19537 | 250 | MG | TABLET | ||||||||
| 114718113 | 11471811 | 5 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 500 MG, UNK | 19537 | 500 | MG | TABLET | ||||||||
| 114718113 | 11471811 | 6 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | 500 MG, UNK | 19537 | 500 | MG | TABLET | ||||||||
| 114718113 | 11471811 | 7 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | 0 | |||||||||||
| 114718113 | 11471811 | 8 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | UNK | 0 | |||||||||||
| 114718113 | 11471811 | 9 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 114718113 | 11471811 | 10 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 114718113 | 11471811 | 11 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | 500 UNK, UNK | 0 | 500 | MG | |||||||||
| 114718113 | 11471811 | 12 | C | ZONEGRAN | ZONISAMIDE | 1 | 100 MG, TID | 0 | 100 | MG | TID | ||||||||
| 114718113 | 11471811 | 13 | C | ZONEGRAN | ZONISAMIDE | 1 | 0 | ||||||||||||
| 114718113 | 11471811 | 14 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 5MG/ 1 AT BED TIME | 0 | 5 | MG | |||||||||
| 114718113 | 11471811 | 15 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 0 | ||||||||||||
| 114718113 | 11471811 | 16 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 114718113 | 11471811 | 17 | C | NITROSTAT | NITROGLYCERIN | 1 | 4 MG, QD | 0 | 4 | MG | QD | ||||||||
| 114718113 | 11471811 | 18 | C | MACROBID | NITROFURANTOINNITROFURANTOIN MONOHYDRATE | 1 | UNK | 0 | |||||||||||
| 114718113 | 11471811 | 19 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | UNK | 0 | |||||||||||
| 114718113 | 11471811 | 20 | C | ABILIFY | ARIPIPRAZOLE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114718113 | 11471811 | 1 | Urinary tract infection |
| 114718113 | 11471811 | 2 | Infection |
| 114718113 | 11471811 | 3 | Urinary tract infection |
| 114718113 | 11471811 | 4 | Urinary tract infection |
| 114718113 | 11471811 | 5 | Urinary tract infection |
| 114718113 | 11471811 | 6 | Urinary tract infection |
| 114718113 | 11471811 | 9 | Infection |
| 114718113 | 11471811 | 10 | Infection |
| 114718113 | 11471811 | 11 | Infection |
| 114718113 | 11471811 | 12 | Pain |
| 114718113 | 11471811 | 13 | Appetite disorder |
| 114718113 | 11471811 | 14 | Pain |
| 114718113 | 11471811 | 15 | Nerve injury |
| 114718113 | 11471811 | 16 | Blood pressure measurement |
| 114718113 | 11471811 | 17 | Myocardial infarction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114718113 | 11471811 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114718113 | 11471811 | Abdominal pain upper | |
| 114718113 | 11471811 | Emotional distress | |
| 114718113 | 11471811 | Gait disturbance | |
| 114718113 | 11471811 | Injury | |
| 114718113 | 11471811 | Nerve injury | |
| 114718113 | 11471811 | Neuralgia | |
| 114718113 | 11471811 | Neuritis | |
| 114718113 | 11471811 | Neuropathy peripheral | |
| 114718113 | 11471811 | Pain | |
| 114718113 | 11471811 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114718113 | 11471811 | 1 | 20101126 | 0 | ||
| 114718113 | 11471811 | 2 | 20111010 | 20111017 | 0 | |
| 114718113 | 11471811 | 3 | 20120302 | 20120322 | 0 | |
| 114718113 | 11471811 | 4 | 20120802 | 20120809 | 0 | |
| 114718113 | 11471811 | 5 | 20120104 | 20120118 | 0 | |
| 114718113 | 11471811 | 6 | 20130924 | 20131004 | 0 | |
| 114718113 | 11471811 | 7 | 2012 | 0 | ||
| 114718113 | 11471811 | 8 | 2012 | 0 | ||
| 114718113 | 11471811 | 9 | 20101110 | 20101117 | 0 | |
| 114718113 | 11471811 | 10 | 20130714 | 20130721 | 0 | |
| 114718113 | 11471811 | 11 | 20121031 | 20121104 | 0 | |
| 114718113 | 11471811 | 16 | 2013 | 2016 | 0 | |
| 114718113 | 11471811 | 17 | 2006 | 0 | ||
| 114718113 | 11471811 | 18 | 201601 | 0 |